| Expression pattern: |
UP |
| Associated gene: |
p-PI3K, p-AKT, PI3K, AKT, N-cadherin, vimentin |
| Associated microRNA: |
- |
| Biological function: |
Promotes breast cancer cell proliferation, migration, invasion, metastasis-related phenotypes and EMT, and inhibits apoptosis; high expression is associated with lymph node metastasis, advanced clinical stage and poor overall survival. |
| Molecular mechanism: |
hsa_circ_001569 promotes breast cancer progression by modulating PI3K-AKT pathway activation; knockdown reduces p-PI3K and p-AKT levels and inhibits EMT marker expression. |
| Biological pathway or process: |
PI3K/AKT (promotes); proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); EMT (promotes); apoptosis (inhibits) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Transfection; CCK8; Colony Formation Assay; Annexin V/PI Flow Cytometry; Wound Healing Assay; Transwell Assay; Western Blot; Cohort Study; Survival Analysis |
| Clinical significance: |
Overexpression is associated with lymph node metastasis, advanced clinical stage and shorter overall survival; hsa_circ_001569 expression is an independent prognostic factor for 5-year overall survival. |
| Description: |
hsa_circ_001569 is up-regulated in breast cancer tissues and cell lines and high expression predicts poor overall survival. Functional knockdown experiments indicate that it promotes proliferation, migration, invasion, metastasis-related behavior and EMT while inhibiting apoptosis. Mechanistically, it contributes to breast cancer progression by activating the PI3K-AKT pathway. |
| Confidence score: |
0.6589 |